NP0341933 | 5,5'-dicapsaicin | | | C36H52N2O6
608.8200 Da 608.38254 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341934 | N-vanillylbutyramide | | | C12H17NO3
223.2720 Da 223.12084 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341935 | N-vanillyl-isobutyramide | | | C12H17NO3
223.2720 Da 223.12084 Da | 1H NMR Spectrum (1D, 500 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3CN, experimental) |
|
NP0341936 | N-vanillyl-capsaicin ether | | | C26H35NO5
441.5680 Da 441.25152 Da | 1H NMR Spectrum (1D, 600 MHz, CD3CN, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) |
|
NP0341943 | Eremoxylarin D | | | C23H32O6
404.5030 Da 404.21989 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0341944 | Eremoxylarin E | | | C25H32O6
428.5250 Da 428.21989 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C6D6, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C6D6, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C6D6, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0341945 | Eremoxylarin F | | | C25H34O6
430.5410 Da 430.23554 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0341946 | Eremoxylarin G | | | C26H34O6
442.5520 Da 442.23554 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0341947 | Eremoxylarin H | | | C26H36O6
444.5680 Da 444.25119 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0341948 | Eremoxylarin I | | | C26H36O6
444.5680 Da 444.25119 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0341949 | Eremoxylarin J | | | C27H36O6
456.5790 Da 456.25119 Da | 1H NMR Spectrum (1D, 500, C3D6O, simulated) | 13C NMR Spectrum (1D, 126 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 500 MHz, C6D6, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C6D6, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C6D6, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C3D6O, experimental) |
|
NP0341950 | Honakeamide A | | | C44H68N2O13S
865.0900 Da 864.44421 Da | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0341955 | 6,7-iso-felinone A | | | C11H16O4
212.2450 Da 212.10486 Da | 1H NMR Spectrum (1D, 500.15991521, CDCl3, simulated) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | [13C, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [13C, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|
NP0341956 | felinone A | | | C11H16O4
212.2450 Da 212.10486 Da | 1H NMR Spectrum (1D, 500.15991521, CDCl3, simulated) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | [13C, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | [13C, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) |
|
NP0341983 | Nocardimicin S | | | C36H53N5O10
715.8450 Da 715.37924 Da | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) |
|
NP0341984 | Nocardimicin T | | | C38H57N5O10
743.8990 Da 743.41054 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0341985 | Nocardimicin U | | | C40H61N5O10
771.9530 Da 771.44184 Da | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0341986 | Nocardimicin V | | | C42H65N5O10
800.0070 Da 799.47314 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0341987 | Nocardimicin W | | | C38H57N5O10
743.8990 Da 743.41054 Da | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) |
|
NP0341996 | polygarinolide A | | | C11H14O6
242.2270 Da 242.07904 Da | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0341997 | Nocardimicin J | | | C40H61N5O10
771.9530 Da 771.44184 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0341998 | nigrosporinol sulfoxide A | | | C15H22O4S
298.4000 Da 298.12388 Da | |
NP0341999 | nigrosporinol sulfoxide B | | | C15H22O3S
282.4000 Da 282.12897 Da | |